NEWS

For our visitors who seek the latest industry news and updates to keep abreast with the goings-on of the business on a global scale, Pharmaceutical Industry portal grants a dynamic and diverse feed of news items.

news

The race for the top of India's fast growing anti-diabetes drugs market is heating up, with the Indian arm of German pharmaceutical drug firm Boehringer Igelheim (BI) accelerating its plans to launch Jardiance, its latest bet in a new class of anti-diabetes drugs named SGLT-2 inhibitors (sodium glucose cotransporter 2).…

news

Pfizer Inc., one of the world's premier innovative biopharmaceutical companies, announced that its injectable contraceptive, Sayana Press (medroxyprogesterone acetate) is now available to women in the United Kingdom for administration by self-injection. This follows the recent approval from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) of an update…

news

Dishman Pharmaceuticals and Chemicals today said it has received a licence from Johnson & Johnson (J&J) to manufacture raw material for a drug used in the treatment of multi drug resistant tuberculosis (MDR-TB). The company holds a licence agreement from Janssen Pharmaceutica NV, one of the pharma companies of Johnson…

news

Drug developer OncoGenex Pharmaceuticals Inc said its experimental combination therapy for pancreatic cancer was not effective in a mid-stage study. The drug, apatorsen, when added to Celegene Corp's combination treatment of Abraxane and chemotherapy drug gemcitabine, did not show any survival benefit when compared with the Abraxane combination alone.  …

news

GlaxoSmithKline may get a green light from European regulators as early as this week for a new biotech medicine to treat severe asthma, boosting prospects for its struggling respiratory business. A recommendation from the European Medicines Agency (EMA) would confirm the British drugmaker's lead in a race to develop an…

news

Elder Pharmaceuticals on Wednesday said its board will meet next week to consider sale of its overseas subsidiaries. A meeting of company's board will be held on September 28 to consider the proposal for sale of step down overseas subsidiaries, Elder Pharma said in a regulatory filing. Facing a severe…

news

Danish drug maker Novo Nordisk will invest 70 million euros ($78 million) to build a manufacturing plant in Iran, joining a small group of European companies to announce concrete deals there since the Islamic Republic reached a nuclear deal in July. Novo Nordisk, the world's largest diabetes drugs maker, has…

news

Indian drugmaker Glenmark Pharmaceuticals is counting on strong growth in the United States, where it will launch a dozen new medicines, to offset weakness in emerging markets this year, its chief executive said. One of India's top 10 drugmakers by sales, Glenmark has seen its profit hit in recent quarters…

news

Mylan NV countersued Perrigo Co on Tuesday over "serious misstatements" it made as part of its defense against an unsolicited $27 billion tender offer by the generic and over-the-counter drugmaker. In a filing in Manhattan federal court, Mylan sought an order requiring Perrigo to correct "false and misleading statements" it…

news

Bausch & Lomb and Nicox announce FDA acceptance of new drug application for novel glaucoma candidate Vesneo (latanoprostene bunod). FDA has set an action date of July 21, 2016 to complete its review, as per the Prescription Drug User Fee Act (PDUFA).   reuters.com